The summary from the EUnetHTA-EFPIA Technical Meeting, held on 2 December 2019 at the Haute Autorité de Santé in Paris, is now available for access. Please find the summary at this link and on the EFPIA site.
The minutes from the EMA-EUnetHTA Bilateral Meeting, hosted by EUnetHTA at the Zorginstituut Nederland (ZIN) in Diemen, Netherlands, on 21st November, 2019, are now available for access. Topics discussed included a follow-up on registries, patient-reported outcomes as part of evidence generation
The minutes from the EMA-EUnetHTA Bilateral Meeting, hosted by the EUnetHTA at the Zorginstituut Nederland (ZIN) in Diemen, Netherlands, on 4th July, 2019, are now available for access. Topics discussed included recent experiences with exchanges on medicinal products, practices and experiences
EUnetHTA is pleased to announce the start of the next Pharmaceutical Joint Assessment. PTJA12 addresses ‘Glasdegib indicated for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (AML)’, submitted by Pfizer. We are delighted that HVB and
The minutes from the EMA-EUnetHTA Meeting, hosted by the European Medicines Agency on 7th December 2018, are now available for access. This was the 16th meeting between the EMA and EUnetHTA, with representatives from both organisations in attendance as well as
The minutes from the EUnetHTA-EFPIA Technical Meeting, held on 11th December 2018 at the Haute Autorité de Santé in Paris, are now available for access. Participants included attendees from both EFPIA and EUnetHTA, as well as the EMA and DG SANTE.
PTJA11 addresses 'cefiderocol the for the treatment of infections due to aerobic Gram-negative bacteria in adult patients with limited treatment options’, submitted by Shionogi BV. We are delighted that AIFA and NOMA are authoring this assessment. We will be issuing an
Open Call for Patient Group Input – Collaborative Assessment on a Medical Device for Rectum Spacers for Prostate Cancer Radiotherapy
EUnetHTA recently started a new Collaborative Assessment on a Medical Device for rectum spacers for prostate cancer radiotherapy. To find out about participation, please read more here. Input submissions will be received through EOB, Friday 5th July.
We are pleased to announce that the collaborative rapid assessment, OTCA11, on "Custom-made or customisable 3D printed implants and cutting guides versus non-3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery"